FDA manufacturing GMP documents
Executive Summary
FDA plans to issue final quality systems guidance by summer, FDA Deputy Commissioner for Medical & Scientific Affairs Scott Gottlieb says March 14 at the International GMP Conference in Athens, Ga. The September 2004 draft guidance, which was part of FDA's final report on its Pharmaceutical cGMP Initiative for the 21st Century, calls for regular analysis of trends in batch quality (1"The Pink Sheet" Oct. 4, 2004, p. 20). FDA also plans to complete a report summarizing "the work of our risk management work group, which was charged with identifying continuous improvements in the risk model for prioritizing sites for manufacturing inspections," Gottlieb adds...
You may also be interested in...
FDA Quality Systems Guidance Suggests “Trending” For Batch Testing
A quality systems approach to manufacturing should include continual monitoring and analysis of trends in batch quality, FDA's quality systems draft guidance states
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.